Synthetic Biologics Inc (SYN.A)

SYN.A on American Stock Exchange

2.50USD
4 Sep 2015
Change (% chg)

$0.29 (+13.12%)
Prev Close
$2.21
Open
$2.18
Day's High
$2.56
Day's Low
$2.18
Volume
77,350
Avg. Vol
177,237
52-wk High
$4.32
52-wk Low
$1.34

SYN.A

Chart for SYN.A

About

Synthetic Biologics, Inc. is a clinical-stage biotechnology company. The Company is developing pathogen-specific therapies for serious infections and diseases, with a focus on protecting the microbiome. It is developing an oral biologic to protect the gut microbiome (gastrointestinal (GI) microflora) from intravenous (IV)... (more)

Overall

Beta: 1.38
Market Cap(Mil.): $221.29
Shares Outstanding(Mil.): 88.52
Dividend: --
Yield (%): --

Financials

  SYN.A Industry Sector
P/E (TTM): -- 66.08 35.95
EPS (TTM): -0.53 -- --
ROI: -- 0.57 14.99
ROE: -- 0.41 15.87
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Ford Investor Services, Inc.
$12.00
Provider : Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks